Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
|
|
Phio Pharmaceuticals Corp. (RXII)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/22/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 04/29/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/22/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/25/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/26/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 03/27/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/26/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/30/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 03/30/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/30/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/28/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/29/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
|
|